The DC‐HIL/syndecan‐4 pathway inhibits human allogeneic T‐cell responses
Open Access
- 6 April 2009
- journal article
- antigen processing
- Published by Wiley in European Journal of Immunology
- Vol. 39 (4) , 965-974
Abstract
T‐cell activation is regulated by binding of ligands on APC to corresponding receptors on T cells. In mice, we discovered that binding of DC‐HIL on APC to syndecan‐4 (SD‐4) on activated T cells potently inhibits T‐cell activation. In humans, we now show that DC‐HIL also binds to SD‐4 on activated T cells through recognition of its heparinase‐sensitive saccharide moiety. DC‐HIL blocks anti‐CD3‐induced T‐cell responses, reducing secretion of pro‐inflammatory cytokines and blocking entry into the S phase of the cell cycle. Binding of DC‐HIL phosphorylates SD‐4's intracellular tyrosine and serine residues. Anti‐SD‐4 Ab mimics the ability of DC‐HIL to attenuate anti‐CD3 response more potently than Ab directed against other inhibitory receptors (CTLA‐4 or programmed cell death‐1). Among leukocytes, DC‐HIL is expressed highest by CD14+ monocytes and this expression can be upregulated markedly by TGF‐β. Among APC, DC‐HIL is expressed highest by epidermal Langerhans cells, an immature type of dendritic cells. Finally, the level of DC‐HIL expression on CD14+ monocytes correlates inversely with allostimulatory capacity, such that treatment with TGF‐β reduced this capacity, whereas knocking down the DC‐HIL gene augmented it. Our findings indicate that the DC‐HIL/SD‐4 pathway can be manipulated to treat T‐cell‐driven disorders in humans.Keywords
This publication has 38 references indexed in Scilit:
- Syndecan-2 and -4 expressed on activated primary human CD4+ lymphocytes can regulate T cell activationMolecular Immunology, 2008
- Human regulatory T cells inhibit polarization of T helper cells toward antigen-presenting cells via a TGF-β-dependent mechanismProceedings of the National Academy of Sciences, 2008
- CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediatorNature Immunology, 2008
- Role of human HGFIN/nmbin breast cancerBreast Cancer Research, 2007
- Differential dysfunction in dendritic cell subsets during chronic HCV infectionClinical Immunology, 2007
- DC-HIL is a negative regulator of T lymphocyte activationBlood, 2007
- Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophagesClinical and Experimental Immunology, 2006
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003
- Transforming Growth Factor β1, in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Interleukin 4, Induces Differentiation of Human Peripheral Blood Monocytes into Dendritic Langerhans CellsJournal of Experimental Medicine, 1998
- nmb, a novel gene, is expressed in low‐metastatic human melanoma cell lines and xenograftsInternational Journal of Cancer, 1995